title: [Evolution of drug treatment of rhabdomyosarcoma in children].
abstract: Rhabdomyosarcoma is the most frequently occurring type of malignant solid tumors in children. The tumor site, aggressive growth, proneness to recurrence, metastatic spreading, and high neglect predetermine the negligible share of the surgical method in multimodality treatment of rhabdomyosarcomas. Of importance are the development and the use of different types and schemes of drug therapy which can be employed in combination with radiotherapy. Drug therapy of rhabdomyosarcomas has large practical potentialities which rise from year to year.
authors.forename: V G
authors.initials: VG
authors.lastname: Poliakov
authors.forename: A F
authors.initials: AF
authors.lastname: Bukhny
authors.forename: I V
authors.initials: IV
authors.lastname: Nechushkina
authors.forename: V M
authors.initials: VM
authors.lastname: Blinov
authors.forename: A V
authors.initials: AV
authors.lastname: Lebedinskiĭ
authors.forename: B M
authors.initials: BM
authors.lastname: Belkina
authors.forename: V I
authors.initials: VI
authors.lastname: Lebedev
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D012208:Rhabdomyosarcoma / Q000188:drug therapy* / Q000532:radiotherapy
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Evoliutsiia lekarstvennogo lecheniia rabdomiosarkom u deteĭ.